International Clinical Trial: Drug for Mycetoma treatment phase 3 study

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607548647895) titled 'Drug for Mycetoma treatment phase 3 study' on July 29.

Study Type: Interventional

Study Design: Single Group,Non-randomised,Allocation Sequence/Code was not concealed

Primary Sponsor: Drug for Neglected Diseases Intiative

Condition: Mycetoma Mycetoma

Recruitment Status: Not Recruiting

Phase: Phase-3

Date of First Enrollment: 31/01/2027

Target Sample Size: 106

Countries of Recruitment: Kenya Kenya Senegal Senegal

To know more, visit https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=43654

Published by HT Digital Content Services with permission from Health Daily Digest....